Inhibition of CK2/ING4 Pathway Facilitates Non‐Small Cell Lung Cancer Immunotherapy

Inhibition of CK2/ING4 Pathway Facilitates Non‐Small Cell Lung Cancer Immunotherapy

Abstract Immune cells can protect against tumor progression by killing cancer cells, while aberrant expression of the immune checkpoint protein PD‐L1 (programmed death ligand 1) in cancer cells facilitates tumor immune escape and inhibits anti‐tumor immunotherapy. As a serine/threonine kinase, CK2 (...

Full description

Bibliographic Details
Main Authors: Qian Gou, Huiqing Chen, Mingjun Chen, Juanjuan Shi, Jianhua Jin, Qian Liu, Yongzhong Hou
Format: Article
Language:English
Published: Wiley 2023-12-01
Series:Advanced Science
Subjects:
CK2
ING4
NSCLC
PD‐1/PD‐L1
tumor immune escape
Online Access:https://doi.org/10.1002/advs.202304068

Internet

https://doi.org/10.1002/advs.202304068

Similar Items